This webinar will be hosted live and available on-demand

Friday, November 15th, 2024
11:30 AM - 12:30 PM ET 

Cell-based treatments such as CAR T cell therapy have potent anticancer effects. However, researchers developing these therapies have several hurdles to overcome, including therapy resistance, side effects, and reduced efficacy in solid tumors. 

In this webinar brought to you by The Scientist, researchers will discuss their efforts to uncover mechanistic challenges and molecular insights that improve cell therapy discovery and development.

Topics to be covered

  • CAR T cell therapy challenges in acute myeloid leukemia (AML), including the complexity of target antigen selection
  • Novel CAR T cell therapy approaches
  • Ex vivo and in vivo CRISPR editing to reprogram T cells
  • Using CRISPR to discover new gene circuits, add synthetic receptors and transcriptional programs, and manufacture next-generation CAR T cells
Paulina Velasquez, MD 

Paulina Velasquez, MD 
Associate Member 
Department of Bone Marrow Transplantation and Cellular Therapy
St. Jude Children’s Research Hospital


Justin Eyquem, PhD

Justin Eyquem, PhD
Assistant Professor
UCSF-Gladstone Institute for Genomic Immunology
Department of Medicine, Hematology & Oncology
University of California, San Francisco


Sponsored by